Biotech pauses trial after second patient death linked to gene therapy ...Middle East

Washington Post - Economy
Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.

Hence then, the article about biotech pauses trial after second patient death linked to gene therapy was published today ( ) and is available on Washington Post ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biotech pauses trial after second patient death linked to gene therapy )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News